Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

John Brooks Recovery Center expands hours for Medication Assisted Treatment Program

JBRC's MAT Program will now offer evening hours at its Pleasantville location.


News provided by

John Brooks Recovery Center

Jul 20, 2021, 03:25 ET

Share this article

Share toX

Share this article

Share toX

John Brooks Recovery Center expands hours for Medication Assisted Treatment Program.
John Brooks Recovery Center expands hours for Medication Assisted Treatment Program.

PLEASANTVILLE, N.J., July 20, 2021 /PRNewswire-PRWeb/ --In an effort to serve more people in and around Atlantic County, John Brooks Recovery Center (JBRC) has announced it will now offer evening hours for its Medication Assisted Treatment (MAT) Program at its Pleasantville location.

"MAT is a long-term approach to recovery that includes the use of medications (i.e., methadone/suboxone/vivitrol) in combination with counseling and behavioral therapies as an effective form of treatment for opioid use disorders," said Michael Santillo, CEO of JBRC. "By expanding our hours into the evening, we'll make MAT more accessible to more people and serve a population of people we have not been able to serve thus far."

“MAT is a long-term approach to recovery that includes the use of medications (i.e., methadone/suboxone/vivitrol) in combination with counseling and behavioral therapies as an effective form of treatment for opioid use disorders,” said Michael Santillo, CEO of JBRC.

Post this

The new evening hours will be Monday through Saturday from 5pm to 11pm at JBRC's Pleasantville location at 660 Black Horse Pike. These hours are in addition to the MAT Program's normal hours Monday through Friday from 6am to 1pm and Saturday from 6am to 12pm in both Pleasantville and Atlantic City at 1931 Bacharach Boulevard.

As part of this MAT program, JBRC offers the following treatment services: Medication Assisted Treatment; individual, group and family counseling; psychoeducation classes; peer recovery support services; case management services; HIV/HEP C testing; counseling, prevention, treatment, and nurse care coordination, HEP A and B vaccines. "Our ultimate goal is to treat the whole person by integrating primary health care, behavioral health care and recovery support services," said Michael Santillo, CEO of JBRC.

JBRC's MAT treatment program is staffed by professionals in the areas of medical, clinical and administrative expertise. "Patients will receive individually prescribed methadone/suboxone medication from a licensed physician or Advanced Practice Nurse," said Santillo. "You will also meet regularly with a counselor, attend groups and access ancillary services as needed."

According to JBRC, the use of medication such as methadone and suboxone coupled with counseling has proven in numerous studies to be one of the most effective treatments for opioid use disorder. "These medicines eliminate withdrawal symptoms and dramatically reduce cravings, allowing an individual to focus on their treatment and recovery," said Santillo. "They also dramatically reduce the incidence of overdoses, as well as the spread of HIV and HEP C."

The MAT Program's expansion of hours aligns directly with JBRC's mission to provide the highest quality, evidence-based treatment services to help individuals overcome substance use disorders regardless of financial circumstance or socio-economic background. "As soon as individuals come through our door, whether it be for primary care or substance use disorder treatment, they will be screened for physical health needs, substance use disorder and mental health treatment," said Santillo. "This allows us to finally bridge the gap between primary health care and behavioral health care and give patients back what they need most – their quality of life."

If you or someone you know is struggling with a substance use disorder, please call JBRC today. For Residential Programs – Residential Detox/Withdrawal Management, Short-term Residential or Long-term Residential, please call 609-345-0110. For Outpatient Programs – Opioid Treatment Program, Intensive Outpatient Program or Standard Outpatient Program, please call 609-345-2020, extension 6182, 6180 or 6179.

About John Brooks Recovery Center
Founded in 1969, John Brooks Recovery Center provides quality, individualized treatment services to help individuals overcome substance use disorders. Programs include: Residential, Outpatient, Medication-assisted Recovery, Detox and Inmate Re-entry. To learn more, visit https://www.jbrcnj.org or visit them on Facebook @JohnBrooksRecoveryCenter.

About All Roads Recovery Community Center
All Roads Recovery Community Center, the community-based recovery arm of JBRC, helps anyone struggling with addiction navigate their next steps on the journey to recovery. All Roads currently offers a wide variety of Recovery Groups, as well as one-on-one coaching with Certified Peer Recovery Specialists (CPRS). To learn more, visit allroadsrecovery.org, call 609-457-1080 or visit them on Facebook @AllRoadsRCC.

Media Contact

Laura Crossan, Design 446, 732-292-2400, [email protected]

SOURCE John Brooks Recovery Center

Related Links

https://www.jbrcnj.org

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.